Press release
United States Bone Densitometer Devices Market is to reach US$ 366.27 million by 2033-Driven by Blockchain Adoption and Privacy Regulations | DataM Intelligence 2025
Image credit goes to: halomedicals.com
Rising osteoporosis cases, aging populations, and growing bone health awareness are driving the Bone Densitometer Devices Market. Advancements in AI-based imaging and early diagnosis programs further boost demand..
Download Free sample report:- https://www.datamintelligence.com/download-sample/bone-densitometer-devices-market?pratik
Recent Product Launches in the US Market :
✅ Osteoboost launched an FDA-cleared wearable vibration therapy device for osteoporosis treatment in Q2 2025.
✅ Echolight partnered with Siemens to resell its radiation-free ultrasound bone densitometer, announced Nov 2024.
✅ Hologic introduced a multi-disease assessment bone densitometer platform in late 2025.
Recent Product Launches in the Japan Market :
✅ Fujifilm released "FDX Visionary-DR" 3D-DXA machine with advanced bone structure imaging in 2025.
✅ Osteosys obtained CE marking for DXA devices compliant with EU medical regulations in 2025.
✅ Portable AI-enabled densitometers gained traction for convenient osteoporosis screening in primary care.
Growth Drivers:-
-The market is valued at USD 364.5 million in 2025 and expected to reach USD 539 million by 2035, growing at 4.0% CAGR due to rising osteoporosis and aging populations.
-DEXA remains the gold standard for bone density assessment, supported by technological advances like 3D-DXA and AI improving diagnostic accuracy.
-Increasing preventive healthcare focus, enhanced reimbursement policies, and better healthcare infrastructures boost market adoption globally.
-Growing awareness of bone health and rising fracture risks lead to higher demand for early diagnosis and treatment monitoring tools.
-Innovations in portable, cost-effective densitometers and digital integration with patient management drive market expansion.
Market Segmentation Analysis
By Technology
-Dual Energy X-Ray Absorptiometry (DXA) leads with 49.8% market share in 2025 due to high precision and clinical accuracy.
-Peripheral Bone Densitometer accounts for 57.6% revenue share, favored for portability, affordability, and ease of use.
-Other technologies include pDXA (peripheral DXA), Quantitative Ultrasound (QUS), and others supporting flexible diagnostic applications.
By Device Type
-Axial Bone Densitometers dominate clinical settings with detailed bone density measurement capability.
-Peripheral Bone Densitometers widely used in community and outpatient screening for osteoporosis risk assessment.
By Application
-Hospitals are the largest users due to comprehensive diagnostics and treatment planning needs.
-Diagnostic Imaging Centers and Specialty Clinics follow, leveraging portable and advanced densitometers for patient care.
By End-User
-Geriatric patients and postmenopausal women are primary end-users, driven by osteoporosis prevalence.
-Increasing awareness and preventive healthcare programs boost adoption among primary care and outpatient users.
"Secure your 30% year-end discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=bone-densitometer-devices-market?pratik ((Purchase 2 or more Repots and get 50% Discount)
The Bone Densitometer Devices Market report would provide approximately
70 key tables
66 visually impactful figures
176 pages
Regional Insights:-
United States
The U.S. bone densitometer market was valued at USD 364.5 million in 2025 and is projected to reach USD 539 million by 2035, growing at a 4.0% CAGR.
-Rising osteoporosis prevalence and aging population drive diagnostic demand.
-Advanced DEXA technology adoption and preventive healthcare expansion boost growth.
-Strong healthcare infrastructure and reimbursement policies support market growth.
Japan
Japan's bone densitometer market is growing due to an aging population and increasing osteoporosis awareness.
-The market benefits from government health initiatives and preventive screening programs.
-Adoption of advanced 3D-DXA and AI-enabled densitometers is increasing.
-Hospitals and clinics prioritize bone health diagnostics for fracture risk assessment.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/bone-densitometer-devices-market?pratik?pratik
Key Players:
According to DataM Intelligence, market leaders such GE Healthcare, Hologic, Inc., Swissray, DMS Group, BeamMed Ltd., OSTEOSYS Corp., FURUNO ELECTRIC CO., LTD., Pinyuan Medical, CyberLogic, Inc., and Aarna Systems and Wellness Pvt. Ltd., among others.
Key Highlights:
GE Healthcare leads the bone densitometer market with advanced DEXA systems, holding the largest global share and driving innovation in bone density diagnostics.
Hologic, Inc. offers comprehensive bone densitometry platforms combining osteoporosis, cardiovascular, and obesity assessment, enhancing multi-disease diagnostics.
Swissray focuses on high-precision imaging and portable bone densitometer devices expanding point-of-care accessibility.
DMS Group integrates AI and software solutions with bone densitometers to improve diagnosis accuracy and patient data management.
BeamMed Ltd. develops radiation-free ultrasound bone densitometer technologies promoting safer diagnostic options for diverse clinical settings.
Key development& FDA Approval :-
The market is valued at USD 364.5 million in 2025, expected to reach USD 539 million by 2035, growing at 4.0% CAGR.
Rising osteoporosis and aging population increase demand for early diagnosis and monitoring.
DEXA technology dominates with over 64% market share as the clinical gold standard.
Technological advances include 3D-DXA, AI integration, and portable devices for improved accuracy and accessibility.
Hospitals account for 56% of market revenue due to comprehensive diagnostic capabilities and budgets.
Market growth is supported by increasing healthcare spending, awareness, and preventive care programs.
Related Report:-
Osteoporosis Testing Market :-https://www.datamintelligence.com/download-sample/osteoporosis-testing-market?pratik
Cystic Fibrosis Market :https://www.datamintelligence.com/download-sample/cystic-fibrosis-market?pratik
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights
through pricing analysis, market share breakdowns, and competitive intelligence. The
company specializes in strategic reports that guide businesses in high-growth sectors such
as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,
LinkedIn and Facebook.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Bone Densitometer Devices Market is to reach US$ 366.27 million by 2033-Driven by Blockchain Adoption and Privacy Regulations | DataM Intelligence 2025 here
News-ID: 4261949 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
China Autonomous Last-Mile Delivery Market 2032: Impact of AI, Robotics & E-comm …
China Autonomous Last-Mile Delivery Market reached US$4.37 billion in 2024 and is expected to reach US$15.98 billion by 2032, growing with a CAGR of 17.60% during the forecast period 2025-2032.
China Autonomous Last-Mile Delivery Market demonstrated strong resilience and steady growth in its initial phase, rising from US$ 3.06 billion in 2022 to US$ 3.72 billion in 2023.
ground delivery vehicles segment expanded from US$ 1.14 billion in 2022 to US$…
United States Active Pharmaceutical Ingredients (API) Market Size to Grow US$ 42 …
active pharmaceutical ingredients market size reached US$ 238.7 Billion in 2024 from US$ 224.7 Billion in 2023 and is expected to reach US$ 428.5 Billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033.
synthetic APIs segment, based on type of synthesis, led the active pharmaceutical ingredients market, accounting for a 58.85% revenue share in 2024.
North America is projected to lead the global active pharmaceutical ingredients market,…
North America Quick Service Restaurant (QSR) Market 2032 | Industry Developments …
Global Quick Service Restaurant Market reached US$ 450.1 billion in 2024 and is expected to reach US$ 635.2 billion by 2032 growing with a CAGR of 4.4% during the forecast period 2025-2032.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/quick-service-restaurant-market?kb
United States: Recent Industry Developments
✅ December 2025: Leading QSR chains introduced expanded plant-based menu options to attract health- and sustainability-oriented consumers.
✅ November 2025:…
Liquid Hydrogen Market Set for Strong Growth to USD 65.9 Billion by 2032, Led by …
The Global Liquid Hydrogen Market reached USD 42.3 billion in 2024 and is expected to reach USD 65.9 billion by 2032, growing at a CAGR of 5.7% during the forecast period 2025-2032.
Market growth is driven by escalating demand for clean energy carriers in transportation and power generation, supportive government policies promoting hydrogen infrastructure, and expanding applications in aerospace and heavy industry. Advancements in liquefaction technologies, rising investments in hydrogen supply…
More Releases for DXA
Bone Mineral Densitometry (BMD) Market to Reach USD 1.64 Billion by 2034
Pune, India, November 7, 2025 - The Global Bone Mineral Densitometry (BMD) Market is projected to grow from USD 985 million in 2024 to approximately USD 1.64 billion by 2034, registering a CAGR of 5.1 % during 2025-2034, according to Exactitude Consultancy. Rising osteoporosis prevalence, post-menopausal bone-loss cases, and awareness of early-stage screening are the key factors sustaining long-term market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/48046
Key…
Fast and Accurate Bone Mineral Density Measurement Device InAlyzer AIR | MEDIKOR …
MEDIKORS leads the field in diagnostic imaging by delivering preclinical DXA systems for research and clinical-grade solutions like the InAlyzer AIR. Designed to enhance bone health diagnostics, the InAlyzer AIR uses 64-channel linear array detection and TRUE fan-beam DXA technology to deliver high-resolution RAW images in just 30 seconds. This non-invasive, compact device provides exceptional accuracy, speed, and patient comfort, making it ideal for osteoporosis diagnosis, body composition analysis, and…
Advanced Imaging Technology for Accurate Bone Diagnosis | MEDIKORS
MEDIKORS offers both clinical and preclinical DXA (Dual-energy X-ray Absorptiometry) devices. For preclinical applications, their InAlyzer system is designed for small animal research. This small animal DXA device supports various scan sizes to accommodate different animal models. Also, the mouse DXA is a high-resolution DXA system used in preclinical research to analyze bone and body composition in small animals. In the clinical setting, MEDIKORS offers the InAlyzer AIR, a DXA…
Revolutionizing Small Animal Research with InAlyzer's High-Resolution DXA Techno …
In the fields of biomedical research, bioscience, and pharmacology, the demand for precise, non-invasive analysis tools is critical. The InAlyzer, a high-resolution small animal DXA (Dual-Energy X-ray Absorptiometry) system developed by MEDIKORS, has become a game-changer for researchers working with small laboratory animals. Specifically designed to measure bone mineral density diagnosis (BMD), bone mineral content (BMC), fat, and lean mass, InAlyzer sets a new benchmark for accuracy, speed, and ease…
InAlyzer Advancing Animal Research Through Precision DXA Technology | MEDIKORS
InAlyzer is a cutting-edge solution from Medikors that leverages DXA technology to revolutionize experimental animal research. It delivers outstanding accuracy, with measurement errors of less than 1% for critical parameters such as BMD, BMC, fat, and lean tissue. It is recognized by prestigious research institutions across the United States, Germany, Spain, Denmark, Norway, China, and India.
Speed Meets Precision
InAlyzer is a revolutionary chemical processing method that significantly enhances the speed and…
The NASA has been used the Small Animal DXA 'InAlyzer' for MHU-8 project | MEDIK …
MEDIKORS InAlyzer was finally selected as the equipment to be used for NASA's space environment biological research, after competing with body composition research equipment around world.
InAlyzer is the world-first 108µm DXA (Dual energy X-ray Absorptiometry) body composition analyzer for lab animals in 2014 and it provides Bone Mineral Density and body composition results due to total body high resolution imaging within 1 minute.
With fast imaging, you can quick access…
